BLUTT MITCHELL J MD
Insider CIK 1097955 · CHFW Director, 10% owner · VCEL 10% owner · QCOR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRZN Surrozen, Inc./DE | S Sale deriv | 2022-12-14 | 2022-12-15 | 432,639 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | S Sale deriv | 2022-12-14 | 2022-12-15 | 150,275 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | S Sale deriv | 2022-12-14 | 2022-12-15 | 144,666 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | S Sale deriv | 2022-12-14 | 2022-12-15 | 582,916 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | S Sale | 2022-12-14 | 2022-12-15 | 1,297,922 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | S Sale | 2022-12-14 | 2022-12-15 | 450,827 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | S Sale | 2022-12-14 | 2022-12-15 | 1,885,000 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | S Sale | 2022-12-14 | 2022-12-15 | 1,748,750 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2021-08-11 | 2021-08-13 | 42,966 | — | $0 | 42,966 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2021-08-11 | 2021-08-13 | 123,700 | — | $0 | 123,700 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2021-08-11 | 2021-08-13 | 166,667 | — | $0 | 166,667 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2021-08-11 | 2021-08-13 | 308,940 | — | $0 | 432,640 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2021-08-11 | 2021-08-13 | 416,250 | — | $0 | 582,917 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2021-08-11 | 2021-08-13 | 107,309 | — | $0 | 150,275 | SEC↗ |
| SRZN Surrozen, Inc./DE | D To issuer | 2021-08-11 | 2021-08-13 | 500,000 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award | 2021-08-11 | 2021-08-13 | 500,000 | — | $0 | 500,000 | SEC↗ |
| SRZN Surrozen, Inc./DE | D To issuer | 2021-08-11 | 2021-08-13 | 371,100 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | D To issuer | 2021-08-11 | 2021-08-13 | 128,900 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award | 2021-08-11 | 2021-08-13 | 128,900 | — | $0 | 128,900 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award | 2021-08-11 | 2021-08-13 | 1,248,750 | — | $0 | 1,748,750 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award | 2021-08-11 | 2021-08-13 | 926,822 | — | $0 | 1,297,922 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award | 2021-08-11 | 2021-08-13 | 321,928 | — | $0 | 450,828 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award | 2021-08-11 | 2021-08-13 | 371,100 | — | $0 | 371,100 | SEC↗ |
| CHFW Consonance-HFW Acquisition | A Award deriv | 2020-12-01 | 2021-05-19 | 8,000 | — | $0 | 144,667 | SEC↗ |
| CHFW Consonance-HFW Acquisition | A Award | 2020-12-01 | 2021-05-19 | 24,000 | — | $0 | 434,000 | SEC↗ |
| CHFW Consonance-HFW Acquisition | P Buy deriv | 2020-12-01 | 2020-12-03 | 8,000 | — | $0 | 144,667 | SEC↗ |
| CHFW Consonance-HFW Acquisition | P Buy | 2020-12-01 | 2020-12-03 | 24,000 | — | $0 | 434,000 | SEC↗ |
| CHFW Consonance-HFW Acquisition | A Award deriv | 2020-11-23 | 2021-05-19 | 136,667 | — | $0 | 136,667 | SEC↗ |
| CHFW Consonance-HFW Acquisition | A Award | 2020-11-23 | 2021-05-19 | 410,000 | — | $0 | 410,000 | SEC↗ |
| CHFW Consonance-HFW Acquisition | P Buy deriv | 2020-11-23 | 2020-11-25 | 136,667 | — | $0 | 136,667 | SEC↗ |
| CHFW Consonance-HFW Acquisition | P Buy | 2020-11-23 | 2020-11-25 | 410,000 | — | $0 | 410,000 | SEC↗ |
| CHFW Consonance-HFW Acquisition | P Buy | 2020-11-23 | 2020-12-04 | 128,900 | — | $0 | 128,900 | SEC↗ |
| CHFW Consonance-HFW Acquisition | P Buy | 2020-11-23 | 2020-12-04 | 371,100 | — | $0 | 371,100 | SEC↗ |
| CHFW Consonance-HFW Acquisition | P Buy | 2020-11-23 | 2020-12-04 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CHFW Consonance-HFW Acquisition | S Sale | 2020-11-18 | 2021-05-19 | 30,000 | $0.01 | $300 | 2,240,000 | SEC↗ |
| CHFW Consonance-HFW Acquisition | S Sale | 2020-11-18 | 2021-05-19 | 30,000 | $0.01 | $300 | 2,210,000 | SEC↗ |
| CHFW Consonance-HFW Acquisition | S Sale | 2020-11-18 | 2021-05-19 | 30,000 | $0.01 | $300 | 2,270,000 | SEC↗ |
| CHFW Consonance-HFW Acquisition | D To issuer | 2020-11-10 | 2021-05-19 | 575,000 | — | $0 | 2,300,000 | SEC↗ |
| CHFW Consonance-HFW Acquisition | D To issuer | 2020-10-08 | 2021-05-19 | 718,750 | — | $0 | 2,875,000 | SEC↗ |
| CHFW Consonance-HFW Acquisition | A Award | 2020-09-04 | 2021-05-19 | 3,593,750 | $0.01 | $35.9K | 3,593,750 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2016-03-28 | 2016-03-29 | 120,000 | $5.39 | $646.8K | 2,232,940 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2012-09-04 | 2012-09-06 | 7,762 | — | $0 | 2,238 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2012-09-04 | 2012-09-06 | 2,083 | — | $0 | 11,459 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2012-09-04 | 2012-09-06 | 4,885 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2012-09-04 | 2012-09-06 | 14,730 | $47.60 | $701.1K | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2012-09-04 | 2012-09-06 | 7,762 | $14.73 | $114.3K | 14,730 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2012-09-04 | 2012-09-06 | 6,968 | $10.16 | $70.8K | 6,968 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2012-09-04 | 2012-09-06 | 10,000 | $47.60 | $476.0K | 220,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2012-07-02 | 2012-07-05 | 70,000 | $53.11 | $3.72M | 230,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award deriv | 2012-05-10 | 2012-05-14 | 15,214 | — | $0 | 15,214 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2012-05-04 | 2012-05-07 | 115 | — | $0 | 4,885 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise deriv | 2012-05-04 | 2012-05-07 | 11,458 | — | $0 | 13,542 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2012-05-04 | 2012-05-07 | 11,573 | $42.69 | $494.1K | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2012-05-04 | 2012-05-07 | 11,458 | $10.16 | $116.4K | 11,458 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | M Exercise | 2012-05-04 | 2012-05-07 | 115 | $10.16 | $1.2K | 11,573 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer | 2012-05-03 | 2012-05-04 | 79,952 | $43.95 | $3.51M | 300,000 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | S Sale | 2012-05-03 | 2012-05-04 | 79,952 | $43.95 | $3.51M | 300,000 | SEC↗ |